Dr. Lal PathLabs Limited
LALPATHLAB
Ранг среди акций
#4528
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
Цена акции
$20.24
Рыночная капитализация
$3.38B
Изменение (1 день)
-0.53%
Изменение (1 год)
13.61%
Страна
IN
Торговля Dr. Lal PathLabs Limited (LALPATHLAB)
Категория
Healthcare
Выручка компании Dr. Lal PathLabs Limited (LALPATHLAB)
Выручка на Jun 2026 TTM: $319.03M
Согласно последним финансовым отчетам Dr. Lal PathLabs Limited, текущая выручка компании (TTM) составляет $319.03M. В 2024 году компания получила выручку $267.04M больше, чем выручке в 2023 году, которая составила $245.42M. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Dr. Lal PathLabs Limited с 2011 по 2026
Выручка на конец каждого года
| Год | Выручка | Изменить |
|---|---|---|
| 2026 (TTM) | $319.03M | 10.85% |
| 2025 | $287.79M | 7.77% |
| 2024 | $267.04M | 8.81% |
| 2023 | $245.42M | -10.75% |
| 2022 | $274.99M | 27.30% |
| 2021 | $216.01M | 22.32% |
| 2020 | $176.59M | 1.90% |
| 2019 | $173.30M | 6.76% |
| 2018 | $162.33M | 15.38% |
| 2017 | $140.69M | 17.79% |
| 2016 | $119.44M | 13.00% |
| 2015 | $105.71M | -3.94% |
| 2014 | $110.04M | 32.38% |
| 2013 | $83.13M | 23.17% |
| 2012 | $67.49M | 26.76% |
| 2011 | $53.24M | 0.00% |
Выручка аналогичных компаний или конкурентов
| Компания | Выручка | Разница в выручке | Страна |
|---|---|---|---|
| $46.34B | 14,424.25% |
US
|
|
| $25.11B | 7,769.91% |
US
|
|
| $2.71B | 748.55% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 2,210.79% |
US
|
